-
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 29/12/25 )
NAV
₹118.02
Last change
₹-0.65 -0.01%
Fund Size (AUM)
8458.68 Cr
Performance
17.42% (5Y)
Fund Details
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
as of 29/12/25
AUM
8458.68 Cr
Expense Ratio
1.81 %
Benchmark
BSE Healthcare TR INR
ISIN
INF204K01943
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl | -2.06% | 20.91% | 17.42% |
| BSE Healthcare TR INR | 2.79% | 23.3% | 17.18% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.55% |
Lupin Ltd |
7.59% |
Divi's Laboratories Ltd |
6.9% |
Cipla Ltd |
6.33% |
Dr Reddy's Laboratories Ltd |
5.83% |
Apollo Hospitals Enterprise Ltd |
5.63% |
Medplus Health Services Ltd |
3.47% |
Vijaya Diagnostic Centre Ltd |
3.41% |
Ajanta Pharma Ltd |
2.9% |
GlaxoSmithKline Pharmaceuticals Ltd |
2.77% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
17.54% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
16.87% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
14.78% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
14.78% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
14.78% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
16.52% (5Y)
-
